ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Pharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Study

Arun Jakhar,Sartaj Hussain,Mohd Shakir Hussain,Lubna Saifi,Kauser Usman,K.K Sawlani,Sanjay Khattri.




Abstract

Introduction: Diabetes mellitus (DM) is a long-term condition that poses enormous health and economic burden on society. Unfortunately, there is a dearth of such evidence in India. Hence, we sought to estimate the direct cost of antidiabetic medication in the geriatric population.
Aim and Objectives: The aim of this study is to evaluate the pharmacoeconomic of antidiabetic medication in geriatric type 2 diabetes mellitus patients attending outpatient department in a tertiary care teaching hospital
Materials and Methods: The demographic characteristics, clinical characteristics, and treatment profiles of patients were compiled. All diabetic patients who visited an outpatient department had their prescriptions recorded. A pharmacoeconomic analysis of prescribed anti-diabetic medications was conducted.
Results: The study enrolled 600 DM patients, of which 67.83% were males, 32.17 % were females, and the predominant age group was 60-64 years. In 94.54% of patients, the most frequently prescribed antidiabetic drug was metformin 500 mg. In 39.31% of patients, the most frequently prescribed antidiabetic combination was glimepiride 2 mg + metformin 500 mg. Insulin was prescribed in 14.83% of the cases. The percentage cost difference for diabetes medications ranges from 43.010 to 644.444. The monthly cost of monotherapy for most patients with controlled diabetes (31.46%) and uncontrolled diabetes (42.12%) was between 500 and 1000 INR. In addition, the cost of combination therapy ranges between INR 118.91 and INR 300.27.
Conclusion: The costs associated with diabetes are immense and impose a substantial burden on society. Consequently, policymakers should prioritise preventing the disease and its associated problems.

Key words: Pharmacoeconomic, Drug Utilization, Antidiabetic Drug, Diabetes Mellitus, Glimepiride, Metformin.







Bibliomed Article Statistics

20
23
26
22
28
41
R
E
A
D
S

20

10

18

8

21

44
D
O
W
N
L
O
A
D
S
010203040506
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.